Price Chart

Key Stats

Customize
Expense Ratio Discount or Premium to NAV Total Assets Under Management 30-Day Average Daily Volume
0.85% 0.17% 7.179M 957.77
Dividend Yield Turnover Ratio 1 Year Fund Level Flows Max Drawdown (All)
0.00% 15.00% -- Upgrade

Basic Info

Investment Strategy
The investment seeks to maximize total return. Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries. While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants. The fund is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style Mid Cap/Growth
Fixed Income Style --
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Category Index --
Prospectus Objective Specialty - Health
Fund Owner Firm Name BlackRock
Prospectus Benchmark Index
MSCI ACWI NR USD 100.0%
Broad Asset Class Benchmark Index
^MSWNTR 100.0%
Manager Tenure
Erin Xie 0.67 yrs
Jeff Lee 0.67 yrs
Xiang Liu 0.67 yrs

Net Fund Flows Versus Category

View Net Fund Flows. Upgrade now.
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
 
80.00B
60.00B
40.00B
20.00B
0
-20.00B
1 Month
% Rank: --
-- Category Low
-- Category High
1 Year
% Rank: --
-4.628B Category Low
7.419B Category High
3 Months
% Rank: --
-- Category Low
-- Category High
3 Years
% Rank: --
-- Category Low
-- Category High
6 Months
% Rank: --
-- Category Low
-- Category High
5 Years
% Rank: --
-- Category Low
-- Category High
YTD
% Rank: --
-- Category Low
-- Category High
10 Years
% Rank: --
-- Category Low
-- Category High
As of May 31, 2021

Performance Versus Category

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (Price)
--
--
--
--
--
--
--
--
Total Return (NAV)
--
--
--
--
--
--
--
--
Category Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Cat (NAV)
--
--
--
--
--
--
--
--
As of June 17, 2021. Returns for periods of 1 year and above are annualized.

Annual Total Returns Versus Peers

Edit comparables
Name
2014
2015
2016
2017
2018
2019
2020
YTD
--
--
--
--
--
--
--
-0.38%
4.94%
-0.87%
7.51%
22.40%
-8.71%
27.67%
15.90%
12.22%
--
--
--
--
--
--
--
1.60%
--
--
--
--
--
--
--
--
25.60%
4.92%
-22.44%
15.99%
-13.12%
26.81%
24.92%
10.26%
31.16%
5.70%
-19.53%
25.44%
-14.41%
25.51%
23.80%
9.77%
As of June 17, 2021.

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (6-17-21) 0.00%
30-Day SEC Yield --
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio 35.63
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of June 15, 2021

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of June 15, 2021

Asset Allocation

As of June 15, 2021.
Type % Net % Long % Short
Cash 2.97% Upgrade Upgrade
Stock 97.03% Upgrade Upgrade
Bond 0.00% Upgrade Upgrade
Convertible 0.00% Upgrade Upgrade
Preferred 0.00% Upgrade Upgrade
Other 0.00% Upgrade Upgrade

Top 10 Holdings

Name % Weight Price % Change
Genmab A/S
3.34% -- --
BlackRock Cash Funds Treasury SL Agency 3.18% 1.00 0.00%
Seagen Inc Ordinary Shares 2.71% 156.37 1.95%
Intuitive Surgical Inc 2.25% 878.86 -0.69%
Amedisys Inc 2.08% 239.17 -0.87%
Teleflex Inc 1.98% 396.87 -1.53%
Alcon Inc 1.91% 70.22 -0.99%
WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S
1.89% -- --
Straumann Holding AG
1.79% -- --
LHC Group Inc 1.76% 196.81 -1.84%

News

Headline
Wire
Time (ET)
No Data Available

Basic Info

Investment Strategy
The investment seeks to maximize total return. Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries. While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants. The fund is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style Mid Cap/Growth
Fixed Income Style --
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Category Index --
Prospectus Objective Specialty - Health
Fund Owner Firm Name BlackRock
Prospectus Benchmark Index
MSCI ACWI NR USD 100.0%
Broad Asset Class Benchmark Index
^MSWNTR 100.0%
Manager Tenure
Erin Xie 0.67 yrs
Jeff Lee 0.67 yrs
Xiang Liu 0.67 yrs

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (6-17-21) 0.00%
30-Day SEC Yield --
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio 35.63
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of June 15, 2021

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of June 15, 2021

Fund Details

Key Dates
Inception Date 9/29/2020
Last Annual Report Date 1/31/2021
Last Prospectus Date --
Attributes
Enhanced Index Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No

News

Headline
Wire
Time (ET)
No Data Available